|
1
|
Robinson DR, Wu YM, Kalyana-Sundaram S,
Cao X, Lonigro RJ, Sung YS, Chen CL, Zhang L, Wang R, Su F, et al:
Identification of recurrent NAB2-STAT6 gene fusions in solitary
fibrous tumor by integrative sequencing. Nat Genet. 45:180–185.
2013.PubMed/NCBI View
Article : Google Scholar
|
|
2
|
Shukla P, Gulwani HV, Kaur S and
Shanmugasundaram D: Reappraisal of morphological and
immunohistochemical spectrum of intracranial and spinal solitary
fibrous tumors/hemangiopericytomas with impact on long-term
follow-up. Indian J Cancer. 55:214–221. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Davanzo B, Emerson RE, Lisy M, Koniaris LG
and Kays JK: Solitary fibrous tumor. Transl Gastroenterol Hepatol.
3(94)2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhang Q, Qin J, Li Y and Wu T: Primary
solitary fibrous tumor of kidney: A case report and literature
review. Urol Case Rep. 23:92–94. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Doyle LA, Vivero M, Fletcher CD, Mertens F
and Hornick JL: Nuclear expression of STAT6 distinguishes solitary
fibrous tumor from histologic mimics. Mod Pathol. 27:390–395.
2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Chmielecki J, Crago AM, Rosenberg M,
O'Connor R, Walker SR, Ambrogio L, Auclair D, McKenna A, Heinrich
MC, Frank DA and Meyerson M: Whole-exome sequencing identifies a
recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet.
45:131–132. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Mohajeri A, Tayebwa J, Collin A, Nilsson
J, Magnusson L, von Steyern FV, Brosjö O, Domanski HA, Larsson O,
Sciot R, et al: Comprehensive genetic analysis identifies a
pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic
imbalances, and a characteristic gene expression profile in
solitary fibrous tumor. Genes Chromosomes Cancer. 52:873–886.
2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Schweizer L, Koelsche C, Sahm F, Piro RM,
Capper D, Reuss DE, Pusch S, Habel A, Meyer J, Göck T, et al:
Meningeal hemangiopericytoma and solitary fibrous tumors carry the
NAB2-STAT6 fusion and can be diagnosed by nuclear expression of
STAT6 protein. Acta Neuropathol. 125:651–658. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Rinaldo L, Xu SCY, Eggers SD, Salomão DR,
Chen JJ and Raghunathan A: Rare occurrence of an intraocular
choroidal solitary fibrous tumor/hemangiopericytoma. Ocul Oncol
Pathol. 4:213–219. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tai HC, Chuang IC, Chen TC, Li CF, Huang
SC, Kao YC, Lin PC, Tsai JW, Lan J, Yu SC, et al: NAB2-STAT6 fusion
types account for clinicopathological variations in solitary
fibrous tumors. Mod Pathol. 28:1324–1335. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kakkar A, Sakthivel P, Rajeshwari M, Kairo
A and Sharma MC: Recurrent sinonasal CD34-negative malignant
solitary fibrous tumor diagnosed on STAT6 immunohistochemistry and
NAB2-STAT6 fusion. Head Neck Pathol. 14:250–256. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Penel N, Amela EY, Decanter G, Robin YM
and Marec-Berard P: Solitary fibrous tumors and so-called
hemangiopericytoma. Sarcoma. 2012(690251)2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Thway K, Ng W, Noujaim J, Jones RL and
Fisher C: The current status of solitary fibrous tumor: Diagnostic
features, variants, and genetics. Int J Surg Pathol. 24:281–292.
2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Schmid S, Csanadi A, Kaifi JT, Kübler M,
Haager B, Kayser G, Passlick B and Wiesemann S: Prognostic factors
in solitary fibrous tumors of the pleura. J Surg Res. 195:580–587.
2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Diebold M, Soltermann A, Hottinger S,
Haile SR, Bubendorf L, Komminoth P, Jochum W, Grobholz R,
Theegarten D, Berezowska S, et al: Prognostic value of MIB-1
proliferation index in solitary fibrous tumors of the pleura
implemented in a new score-a multicenter study. Respir Res.
18(210)2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Fountas KN, Kapsalaki E, Kassam M, Feltes
CH, Dimopoulos VG, Robinson JS and Smith JR: Management of
intracranial meningeal hemangiopericytomas: Outcome and experience.
Neurosurg Rev. 29:145–153. 2006.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Robinson LA: Solitary fibrous tumor of the
pleura. Cancer Control. 13:264–269. 2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ghose A, Guha G, Kundu R, Tew J and
Chaudhary R: CNS hemangiopericytoma: A systematic review of 523
patients. Am J Clin Oncol. 40:223–227. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yuzawa S, Nishihara H, Wang L, Tsuda M,
Kimura T, Tanino M and Tanaka S: Analysis of NAB2-STAT6 gene fusion
in 17 cases of meningeal solitary fibrous tumor/hemangiopericytoma:
Review of the literature. Am J Surg Pathol. 40:1031–1040.
2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Vogels R, Macagno N, Griewank K, Groenen
P, Verdijk M, Fonville J and Kusters B: French CNS SFT/HPC
Consortium; Dutch CNS SFT/HPC Consortium. Figarella-Branger D, et
al: Prognostic significance of NAB2-STAT6 fusion variants and TERT
promotor mutations in solitary fibrous tumors/hemangiopericytomas
of the CNS: Not (yet) clear. Acta Neuropathol. 137:679–682.
2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
England DM, Hochholzer L and McCarthy MJ:
Localized benign and malignant fibrous tumors of the pleura. A
clinicopathologic review of 223 cases. Am J Surg Pathol.
13:640–658. 1989.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Piri R, Ghaffari A, Azami-Aghdash S,
Ali-Akbar YP, Saleh P and Naghavi-Behzad M: Ki-67/MIB-1 as a
prognostic marker in cervical cancer-a systematic review with
meta-analysis. Asian Pac J Cancer Prev. 16:6997–7002.
2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Prueter J, Norvell D and Backous D: Ki-67
index as a predictor of vestibular schwannoma regrowth or
recurrence. J Laryngol Otol. 133:205–207. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kammerer-Jacquet SF, Ahmad A, Møller H,
Sandu H, Scardino P, Soosay G, Beltran L, Guzick J and Berney DM:
Ki-67 is an independent predictor of prostate cancer death in
routine needle biopsy samples: Proving utility for routine
assessments. Mod Pathol. 32:1303–1309. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Go SI, Ko GH, Lee WS, Lee JH, Jeong SH,
Lee YJ, Hong SC and Ha WS: The use of CD44 variant 9 and Ki-67
combination can predicts prognosis better than their single use in
early gastric cancer. Cancer Res Treat. 51:1411–1419.
2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yamamoto Y, Hayashi Y and Murakami I:
Recurrence of solitary fibrous tumor/hemangiopericytoma could be
predicted by Ki-67 regardless of its origin. Acta Med Okayama.
74:335–343. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Hayashi Y, Osanai M and Lee GH: Fascin-1
expression correlates with repression of E-cadherin expression in
hepatocellular carcinoma cells and augments their invasiveness in
combination with matrix metalloproteinases. Cancer Sci.
102:1228–1235. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang CQ, Tang CH, Chang HT, Li XN, Zhao
YM, Su CM, Hu GN, Zhang T, Sun XX, Zen Y, et al: Fascin-1 as a
novel diagnostic marker of triple-negative breast cancer. Cancer
Med. 5:1983–1988. 2016.PubMed/NCBI View
Article : Google Scholar
|
|
29
|
Arlt MJ, Kuzmanov A, Snedeker JG, Fuchs B,
Silvan U and Sabile AA: Fascin-1 enhances experimental osteosarcoma
tumor formation and metastasis and is related to poor patient
outcome. BMC Cancer. 19(83)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Barthelmeß S, Geddert H, Boltze C,
Moskalev EA, Bieg M, Sirbu H, Brors B, Wiemann S, Hartmann A,
Agaimy A and Haller F: Solitary fibrous tumors/hemangiopericytomas
with different variants of the NAB2-STAT6 gene fusion are
characterized by specific histomorphology and distinct
clinicopathological features. Am J Pathol. 184:1209–1218.
2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Doyle LA: Sarcoma classification: An
update based on the 2013 World Health Organization classification
of tumors of soft tissue and bone. Cancer. 120:1763–1774.
2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Jo VY and Fletcher CD: WHO classification
of soft tissue tumours: An update based on the 2013 (4th) edition.
Pathology. 46:95–104. 2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Macagno N, Vogels R, Appay R, Colin C and
Mokhtari K: French CNS SFT/HPC Consortium; Dutch CNS SFT/HPC
Consortium. Küsters B, Wesseling P, Figarella-Branger D, et al:
Grading of meningeal solitary fibrous tumors/hemangiopericytomas:
Analysis of the prognostic value of the marseille grading system in
a cohort of 132 patients. Brain Pathol. 29:18–27. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Richmond AM, Blake EA, Torkko K, Smith EE,
Spillman MA and Post MD: Fascin is associated with aggressive
behavior and poor outcome in uterine carcinosarcoma. Int J Gynecol
Cancer. 27:1895–1903. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Apra C, Alentorn A, Mokhtari K,
Kalamarides M and Sanson M: Pazopanib efficacy in recurrent central
nervous system hemangiopericytomas. J Neurooncol. 139:369–372.
2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Martin-Broto J, Stacchiotti S, Lopez-Pousa
A, Redondo A, Bernabeu D, de Alava E, Casali PG, Italiano A,
Gutierrez A, Moura DS, et al: Pazopanib for treatment of advanced
malignant and dedifferentiated solitary fibrous tumour: A
multicentre, single-arm, phase 2 trial. Lancet Oncol. 20:134–144.
2019.PubMed/NCBI View Article : Google Scholar
|
